Diabetes Research and Clinical Practice
Volume 56, Issue 3 , Pages 207-211 , June 2002

Process measures and outcome research as tools for future improvement of diabetes treatment quality

Received 12 June 2001 ,Revised 11 December 2001 ,Accepted 18 December 2001.

References 

  1. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with onset of diabetes before the age of thirty-one. I. Survival, causes of death, and complications. Diabetologia. 1978;14:363–370
  2. Kannel WB, McGee DL. Diabetes and cardiovascular disease: The Framingham Study. J. Am. Med. Assoc. 1979;241:2035–2038
  3. Parving H-H, Hommel E, Mathiesen ER, Skøtt P, Edsberg B, Bahnsen M, et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin-dependent diabetes. Br. Med. J. 1988;296:156–160
  4. Crall FV, Roberts WC. The extramural and intramural coronary arteries in juvenile diabetes mellitus. Analysis of nine necropsy patients aged 19 to 38 years with onset of diabetes before age 15 years. Am. J. Med. 1978;64:221–230
  5. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall Study. Br. Med. J. 1983;287:867–870
  6. Jarrett RJ, McCartney P, Keen H. The Bedford Study: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia. 1982;22:79–84
  7. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993;329:977–986
  8. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  9. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br. Med. J. 1998;317:703–713
  10. Gæde P, Vedel P, Parving H-H, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet. 1999;353:617–622
  11. Pyorala K, Pedersen TR, Kjeksus J, Færgeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 1997;20:614–620
  12. Feldt-Rasmussen B, Dinesen B, Deckert T. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand. J. Clin. Lab. Invest. 1985;45:539–544
  13. Peters AL, Legoretta AP, Ossorio RC, Davidson MB. Quality of outpatient care provided to diabetic patients. A health maintenance organisation experience. Diabetes Care. 1996;19:601–606
  14. Sandø SH, Hagen C, Beck-Nielsen H. A method to measure quality of diabetes treatment: results from an outpatient clinic. Int. J. Qual. Health Care. 1994;6:47–54
  15. Peters AL, Davidson MB. Application of a diabetes managed care program. The feasibility of using nurses and a computer system to provide effective care. Diabetes Care. 1998;21:1037–1043
  16. Mazze RS, Simonson G. Staged diabetes management. A systematic evidence-based approach to the prevention and treatment of diabetes and its co-morbidities. Pract. Diab. Int. 2001;18:S1–S16

PII: S0168-8227(02)00003-7

Diabetes Research and Clinical Practice
Volume 56, Issue 3 , Pages 207-211 , June 2002

Article Tools